Adaptogenics names J. David Warren CEO, adds him to board

• Adaptogenics named J. David Warren CEO, director effective Oct. 1, 2026; Weill Cornell adjunct professor, ex-director of Milstein Chemistry Core.
• Anthony Franco stepped down as CEO, director effective Oct. 1, 2026.
• Gurinder Sandhu appointed executive vice president, corporate development; remains a director.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptogenics Health Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610020730NEWSFILECNPR____20261002_317007_1) on October 02, 2026, and is solely responsible for the information contained therein.